A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
Ann Rheum Dis
; 74(5): 867-75, 2015 May.
Article
in En
| MEDLINE
| ID: mdl-24412895
Full text:
1
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Triamcinolone
/
Methotrexate
/
Antirheumatic Agents
/
Antibodies, Monoclonal, Humanized
/
Anti-Inflammatory Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2015
Type:
Article